Emerging Role of PD-1/PD-L1 Inhibitors in Chronic Liver Diseases

• المؤلفون الرئيسيون: Vishakha Singh (مؤلف), Amit Khurana (مؤلف), Prince Allawadhi (مؤلف), Anil Kumar Banothu (مؤلف), Kala Kumar Bharani (مؤلف), Ralf Weiskirchen (مؤلف)
• التنسيق: كتاب
• منشور في: Frontiers Media S.A., 2021-12-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Programmed cell death protein 1 (PD-1)/PD-ligand (L)1, the immune checkpoint inhibitors have emerged as a promising strategy for the treatment of various diseases including chronic liver diseases (CLDs) such as hepatitis, liver injury and hepatocellular carcinoma (HCC). The role of PD-1/PD-L1 has be...